A research team from Spain, which was led by Carmen Gallardo, has prepared a Cochrane systematic review that explores the efficacy, safety, and adherence to fixed-dose combinations (FDCs) of drugs versus single-drug formulations to treat people who are newly diagnosed with tuberculosis (TB).

TB is a curable and preventable disease caused by the bacterium Mycobacterium tuberculosis and most often affects the lungs of infected individuals. This disease is found worldwide, and 95% of TB deaths occur in low- and middle-income countries. Also, TB is the leading killer of HIV-positive people.

To read this full news article follow this link and the review can be found on the Cochrane Library here: 
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009913.pub2/full